各イベント詳細
イベント一覧へ戻る

Japan Use of Medicines: A Perspective on an Evolving Market and Outlook to 2022

14 Mar 2018
Information for our guests:

Date Wed, 14-Mar-2018
Start 12:00
End 14:00
Venue Tokyo American Club
Hall/ Room Manhattan 3
Address 2-1-2, Azabudai, Minato-ku, Tokyo 106-8649
Guests Fee (Yen) 7,900
Speaker(s) Alan Thomas (Director, Thought Leadership IQVIA).

The description below is adapted from ACCJ Event Information.

Although now ranked as the 3rd largest market globally, Japan remains the 2nd largest market for brands, specialty, and innovation - and as such remains a strategic market for investment for many companies. However, overall performance in the last few years has been challenging for some and rewarding for others, with pockets of growth still available for pharma companies with the right focus – namely in specialty/biologics, innovation, and elderly-related therapy areas to name a few. Underlying these areas of growth is added pressure on healthcare spend and funding, and related MHLW policy changes and initiatives in recent years to manage this spend and establish a new direction for the market.

Join us to discuss these and other issues impacting the market today and in the coming years. If you are in the healthcare industry, this event is a must.

Alan Thomas joined IMS Japan in 1999 and has held various roles during his time with the organization including marketing, sales and account management, and client relations. In 2016, Alan was appointed to his current role as Director, Thought Leadership at IQVIA, IMS Japan K.K.
イベント一覧へ戻る
[メインページへ]
Copyright(C) MedicaLingual Inc. All Rights Reserved.
本サイトの文章・画像の無断転用、転写はご遠慮下さい。